about
Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798.Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway.Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.[Effect of PI3K/AKT pathway on cisplatin resistance in non-small cell lung cancer].
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Akt1 enhances CA916798 expression through mTOR pathway
@ast
Akt1 enhances CA916798 expression through mTOR pathway
@en
Akt1 enhances CA916798 expression through mTOR pathway
@nl
type
label
Akt1 enhances CA916798 expression through mTOR pathway
@ast
Akt1 enhances CA916798 expression through mTOR pathway
@en
Akt1 enhances CA916798 expression through mTOR pathway
@nl
prefLabel
Akt1 enhances CA916798 expression through mTOR pathway
@ast
Akt1 enhances CA916798 expression through mTOR pathway
@en
Akt1 enhances CA916798 expression through mTOR pathway
@nl
P2093
P2860
P1433
P1476
Akt1 enhances CA916798 expression through mTOR pathway
@en
P2093
Bing-Jing Zhu
Hai-Jing Wang
Xiang-Dong Zhou
Yu-Liang Wang
Zhan-Zhong Qi
P2860
P304
P356
10.1371/JOURNAL.PONE.0062327
P407
P577
2013-01-01T00:00:00Z